Authors
Haifeng Zhang, Yihong Zhang, Yanxuan Ling, Guangqing Jiang, Junjie Wu, Xin Shi, Yupeng Zhao
Published in
Journal of visualized experiments : JoVE. Issue 237. Nov 03, 2026. Epub Nov 03, 2026.
Abstract
Gastric cancer (GC) remains a major cause of cancer mortality. We combined network pharmacology, molecular docking, molecular dynamics simulations, public database analyses, and cell-based assays to investigate stigmasterol and heat shock protein 90 alpha family class A member 1 (HSP90AA1). Computational screening prioritized HSP90AA1 as a candidate target. In AGS and MKN-45 cells, stigmasterol treatment reduced cell viability and DNA synthesis, increased the proportion of Annexin V-positive cells, and decreased HSP90AA1 protein abundance. No statistically significant change in HSP90AA1 mRNA abundance was detected under the conditions tested. Increased ubiquitin signal in HSP90AA1 immunoprecipitates and attenuation of protein loss by MG-132 were consistent with proteasome involvement. Public database analyses showed higher HSP90AA1 expression in GC tissues and an association with clinical stage. These findings link stigmasterol treatment to HSP90AA1 downregulation in GC cells. Direct binding, the contribution of HSP90AA1 loss to the cellular effects, and in vivo efficacy remain to be established.
PMID:
42980202
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 14
- Comments 0